ArticleCase reports in infectious diseases2019
Empyema Necessitans due to Interruption of Antituberculosis Treatment.
Article in Case reports in infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 13 citations in OpenAlex.
- Article
- Comments and Illustrations of the European Federation of Societies for Ultrasound in Medicine Guidelines: Benign Pleura Lesions (Benign Pleura Thickening, Lesions and Masses)-What Can Be Seen on Transthoracic Ultrasound?Diagnostics (Basel, Switzerland) · 2025Review
- Empyema necessitans: a rare presentation ofCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2024Article
- Tuberculous empyema necessitans: Case report of a rare occurrence.Radiology case reports · 2024Article
- Empyema Necessitans: A Case Report.IDCases · 2024Article
- Empyema necessitans (EN) as a rare complication of tuberculosis - A case report.International journal of surgery case reports · 2023Article
- Empyema necessitans in a pediatric patient: A case study.International journal of surgery case reports · 2023Article
- Necrotizing fasciitis of the chest wall caused by empyema necessitans following tuberculosis: Case report and literature review.International journal of surgery case reports · 2023Article
- A case of empyema necessitans in an adolescent with mycobacterium tuberculosis.Annals of medicine and surgery (2012) · 2022Article
- Empyema necessitans mimicking mesothelioma; unusual presentation of active pulmonary TB in immuno-competent state.Annals of medicine and surgery (2012) · 2022Article
- A Rare and Challenging Presentation of Empyema Necessitans/Necessitasis Leading to Brachial Plexopathy.Cureus · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Empyema necessitans is a rare presentation of tuberculous infection, commonly encountered in immunocompromised patients. The diagnosis can be challenging due to the paucibacillary nature of the condition and nonspecific symptoms. Identifying the organism in culture is the gold standard method of diagnosis. We describe a patient with chronic kidney disease, who developed empyema necessitans due to interruption of antituberculous therapy. Initially, he was started on antituberculous therapy based on a clinical diagnosis of smear-negative pulmonary tuberculous infection; this resulted in Stevens-Johnson syndrome needing a long course of steroid therapy. He later presented with a painful chest lump and was diagnosed as empyema necessitans. Finding the etiology for this rare presentation lead to a diagnostic dilemma, finally confirming the TB infection from the culture. This case highlights the importance of being aware of unusual complications of tuberculous infection in immunocompromised settings.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.